Stay updated on CB-839 in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the CB-839 in Solid Tumors Clinical Trial page.

Latest updates to the CB-839 in Solid Tumors Clinical Trial page
- Check2 days agoChange DetectedThe footer revision label changes from v3.7.2 to v3.8.0; the page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check9 days agoChange DetectedThe study record page displays a 403 Forbidden message with a Home link. An NIH notice about its website transition also appears at the top.SummaryDifference2%

- Check16 days agoChange DetectedThe footer’s site revision identifier changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check23 days agoChange DetectedThe footer’s site revision identifier changes from v3.7.0 to v3.7.1, while the page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check44 days agoChange DetectedThe page renders a 403 Forbidden error instead of the study details, with an error header and a Home link; this indicates the study record is currently inaccessible and the prior content appears removed.SummaryDifference20%

- Check65 days agoChange DetectedThe page revision was updated from v3.6.5 to v3.6.6, indicating a new version of the page. This update signals a version change rather than a modification to the study contents or data displayed.SummaryDifference0.0%

Stay in the know with updates to CB-839 in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CB-839 in Solid Tumors Clinical Trial page.